| 000 | 01278 a2200337 4500 | ||
|---|---|---|---|
| 005 | 20250516174202.0 | ||
| 264 | 0 | _c20140929 | |
| 008 | 201409s 0 0 eng d | ||
| 022 | _a1531-6963 | ||
| 024 | 7 |
_a10.1097/BOR.0000000000000000 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDörner, Thomas | |
| 245 | 0 | 0 |
_aB cells: depletion or functional modulation in rheumatic diseases. _h[electronic resource] |
| 260 |
_bCurrent opinion in rheumatology _cMar 2014 |
||
| 300 |
_a228-36 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aAntibodies, Monoclonal, Humanized _xtherapeutic use |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal, Murine-Derived _xtherapeutic use |
| 650 | 0 | 4 |
_aAntirheumatic Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aAutoimmune Diseases _ximmunology |
| 650 | 0 | 4 |
_aB-Lymphocytes _ximmunology |
| 650 | 0 | 4 |
_aGerminal Center _ximmunology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunosuppression Therapy _xmethods |
| 650 | 0 | 4 | _aLymphocyte Depletion |
| 650 | 0 | 4 |
_aRheumatic Diseases _ximmunology |
| 650 | 0 | 4 | _aRituximab |
| 700 | 1 | _aLipsky, Peter E | |
| 773 | 0 |
_tCurrent opinion in rheumatology _gvol. 26 _gno. 2 _gp. 228-36 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/BOR.0000000000000000 _zAvailable from publisher's website |
| 999 |
_c23172399 _d23172399 |
||